Term
Dilated Cardiomyopathy
(definition, etiology, sx) |
|
Definition
Definition: most common (95%), reduced ventricular strength--->dilation of LV, systolic d/f
Etiology: genetic (25-30%), alcohol, post-partum, chemo, myocarditis, idiopathic, M(esp. AA)>F
Si/Sx (20-60yo): HF signs: SOB, DOE, orthopnea
Incidental: cardiomegaly, conduction disturbance
|
|
|
Term
Dilated Cardiomyopathy
(PE, Labs/dx studies, tx) |
|
Definition
PE: vitals, inc HR. cool skin, peripheral edema, JVD, s3+/-s4, +/-MR
Labs: BNP
Studies: ECG, CX, echo, arteriography (if angina)--->Dx if LV EF <40%, idiopathic if no CAD, myocard, no prim/sec muscle dz
tx: tx for HF; ACE, bb, +/-diuretic--->transplant |
|
|
Term
Hypertrophic Cardiomyopathy
(def, etiology/facts, si/sx) |
|
Definition
def: 4%, hypertrophy-mostly septum, outflow obstruction, small LV, diastolic d/f
eti: genetic, sudden death >30 yo
si/sx: dyspnea (90%), syncope, cp, arrhythmias (AF/vent arr). Sudden death-w/ extreme exertion |
|
|
Term
HCM
(PE, Lab/studies, tx) |
|
Definition
PE: sys murmur increased w/ squat to stand at LSB, s4, bisferiens carotid pulse,
ECG (LVH), CX, echo-asym LVH, sys ant motion of MV, dynamic pressure gradient across LV outflow tract, inc EF, dec diastolic fx
Myocardial perfusion studies
Tx: bb, ccb, dual-ch pacer, septal ablation, myomectomy |
|
|
Term
Restrictive Cardiomyopathy
(def, etiology/facts, si/sx) |
|
Definition
Def: fibrosis/infiltration 2/2 collagen d/f (amyloidosis, radiation, post-op, diabtes) others;sarcoid, hypereosinophilic syn, endomyo fibrosis, hemochromatosis, malignancy
s/s: gradual worsening SOB, early fatigue, weakness, PND, abd pain, cp, palps (AF), syncope |
|
|
Term
|
Definition
PE: JVD, kussmaul sign, +/- s3, murmurs (MR/TR), ascites, edema
studies: CBC, iron studies, BNP
CX-->cardiomegaly w/ pleural effusion, P-HTN
Echo-non-dilated/hypertrophied, normal contraction LV/RV, dilated atria, dec diastolic filling
tx: underlying cause, tx HF, pacemaker, transplant |
|
|
Term
|
Definition
def/facts: Most common, inc w/ age, etiologies include; rheumatic, valvular, dcm, asd, htn, cad, idiopathic-->may be initial sx of thyrotoxicosis
sx: few, fatigue, uncomfortable sensation in chest
dx: ECG, if new; thyroid fx, valve/cardiac dz r/o
Tx: if unstable (usually 2/2 rvr); hospitalization, cardioversion (pre-cardiov anticoag if >48hrs), if more stable-> bb, dig, ccb, amiodorone
anitcoagulation: warfarin (INR 2.0-3.0)
If refractory; node ablation w/ pacing |
|
|
Term
|
Definition
Less common, usually assoc w/ COPD, or rheumatic, CAD, CHF, ASD or surgical repair of congenital defect.
can tx w/ ibultilide (class III anti-arrhythmic), or electrical cardioversion |
|
|
Term
Paroxysmal Supraventricular tachycardia |
|
Definition
most common paroxysmal tachy, often 2/2 reentry, which can is initiated or terminated by fortuitously timed atrial or ventricular premature beat
Most commonly AVNRT-dual pathway w/in AV node
Other is AVRT-reentry d/t accessory pathway b/w atrial+vent
s/s: usually asx, may feel beat, sob, mild cp
Dx: ecg 140-240 bpm
tx: vagal maneuvers, then adenosine (6mg bolus, 1-2min later 12 mg bolus, then 3rd), verapamil (2.5mg bolus, f/by 2.5-5 q1-3 min, tot 20mg) |
|
|
Term
|
Definition
3 or more consecutive vent premature beats, rate = 160-240 bpm, moderatly regular, usually 2/2 reentry, complication of MI, DCM, HCM, MVP, myocarditis, other
Torsades de pointes-qrs twists around baseline, may occur spontaneously in setting of hypokalemia, hypomagnesemia, or after QT interval prolonging drugs
sustained >30s, non-sustained <30s
tx: ACLS guidelines |
|
|
Term
|
Definition
1st deg: PR interval >.21, 2/2 inc vagal tone, drugs
Mobitz type I (Weckebach): progressive lengthening of PR, then dropped beat, inc vagal tone, drugs, usually nodal.
Mobitz Type II: dropped beats w/o PR lengthening, usually 2/2 block w/in his bundle
Complete (3rd deg): lesion distal to his bundle, wide qrs, slow ventricular rate (<50bpm) |
|
|
Term
|
Definition
-Deterioration of sinus node's ability to generate impulse, atrial signal conduction-->slow ventricular rate, long pauses, organ hypoperf, pulse irregularities.
etiologies: age related(fibrosis), CAD, Familial Sick sinus syndrome, Tachy-brady syndrome, bb,ccb, dig, endocrine (hypothyroidism, hypothermia), hypokalemia,hypocalcemia)
s/s: avg age=68,m=w, asx, fatigue, dizzziness, syncope, angina, HF sx, palps |
|
|
Term
|
Definition
PE: slow heart rate (<60bpm w/ activity), +/- irreg pulse, sinus pause>3 sec to carotid sinus massage
Labs; e-, thyroid, ecg, holter, implantable loop recorder, exercise tolerance test, atropine/propranolol test
tx: pacemaker |
|
|
Term
|
Definition
|
|
Term
|
Definition
Fibrinolysis Generally Preferred:
|
Invasive Strategy Generally Preferred:
|
Early presentation (≤ 3 hrs from symptom onset and delay to invasive strategy)
Invasive strategy is not an option Catheterization lab occupied/not available Vascular access difficulties Lack of access to a skilled PCI lab†
Delay to invasive strategy Prolonged transport Door-to-balloon time minus door-to-needle time > 1 hr*‡ Medical contact-to-balloon or door-to-balloon > 90 min
|
Skilled PCI lab available with surgical backup† Medical contact-to-balloon or door-to-balloon < 90 min Door-to-balloon time minus door-to-needle time < 1 hr*
High risk for STEMI Cardiogenic shock Killip class ≥ 3
Contraindications to fibrinolysis (increased risk of bleeding and ICH)
Late presentation (time lapsed since symptom onset > 3 hrs)
Diagnosis of STEMI is in doubt
|
|
|
|
Term
Pericarditis
(definition, etiology, presentation) |
|
Definition
Definition: inflammation of pericardium, acute <6wks, sub-acute 6wks-6mo, chronic (constrictive) >6mo
etiology: Neoplastic, autoimmune, viral, bacterial, idiopathic, uremia, dressler's (s/p MI, cardiac injury)
Presentation: +/- prodrome (malaise, myalgia, fever), CP (like acute MI, retrosternal, steady, severe, constricting, radiates, *improves w/ sitting up, leaning forward*, can be pleuritic |
|
|
Term
Pericarditis
(PE, Dx, Tx) |
|
Definition
PE: friction rub (85%), CP more common in acute,
ECG: diffuse ST elevations, w/ dep in aVr,+/-V1
Labs: ESR/CRP, WBC, CPK, CK-MB, Trops, make sure to r/o MI
Tx w/ NSAIDS, colchicine, steroids, ABx if bacterial |
|
|
Term
Constrictive Pericarditis
(def, etiology, dx, tx) |
|
Definition
Occurs s/p resolution of acute pericarditis-TB, radiation, trauma, surgery, AI, uremia w/ CRF
presents w/ weakness, fatigue, jvd w/ +kussmauls, cong. Hepatomegaly
Dx w/ ECG-diffuse t wave flat/inv, Echo-pericardial thickening
Tx w/ resection of pericardium |
|
|
Term
Pericardial Effusion
(basics) |
|
Definition
accumulation of fluid in pericardial space 2/2 inflammation or bleeding- presents w/ inc cardiac silheutte="water bottle", ewart's si=L scap angle increased fremitus, egophony
dx w/ TTE-small=<100ml, Lg=>500mL
|
|
|
Term
Cardiac Tamponade
(definition, presentation, Dx, Tx) |
|
Definition
Accumulation of enough fluid to obstruct inflow into ventricles
Rapid onset (hrs-days) as little as 200ml, Slow onset (mo-yrs) as much as 2000ml (presents like HF)
Presentation: Beck's triad: hypoT, distant hrt sounds, JVD-also might have pulses parodixus
Dx w/ echo, Tx w/ pericardiocentesis |
|
|
Term
Infective Endocarditis
(definition, Patho, RF) |
|
Definition
Bacterial infection of endothelial surface of heart, typically valves, characterized by vegetations and systemic manifestations-occurs 2/2 turbulent flow
Patho: bacteremia (IVDA, Dental)-->adherence of org-->invasion-->death
RF: valve damage by previous IE, valvular dz, congenital d/f, HIV, IVDU, indwelling caths |
|
|
Term
Infective endocarditis
(Etiology, Presentation) |
|
Definition
Staphylococci (42%), Streptococci (40%) in one study, others; enterococci, GNB, fungi
Presentation: Acute(<6wks) toxic-chills, fevers, rapid onset HF, palps, wt loss, HA, myalgias, Sub-acute (>6wks) milder sx |
|
|
Term
Infective Endocarditis
(Diagnostic Criteria) |
|
Definition
Major Manifestations: +bcx (at least 2 sets), evidence of endocardial involvement-+veg on echo, new onset murmur
Minor manifestations: T>100 dg, +echo (not meeting major), +Bcx (not major), +IVDU, clinical signs-vascular, immunologic abnormalities
Needed: 2maj or 1maj/3min or 5min |
|
|
Term
Infective Endocarditis
("classic" signs) |
|
Definition
Subungual (splinter) hemorrhages, Osler Nodes(tender nodules on digits), Janeway lesions (NT maculae on palms/soles), Roth spots (retinal hemorrhages)
|
|
|
Term
Infective Endocarditis
(Treatment) |
|
Definition
Acute stabilization: tx HF
Empiric Therapy: Penicillin G/Ampicillin + Nafcillin/Oxacillin+Gentamicin
If IVDU/Prosthetic valve: vanco+gentamycin
Identify org, then narrow tx
Surgery may be needed |
|
|
Term
myocarditis
(Definition, etiology, Presentation) |
|
Definition
Inflammation of myocardium-infectious, immune-mediated, toxic exposure
World wide-chagas dz, western-coxsackie B, adeno, parvo B19
Presents: viral prodrome-fever, myalgias, resp/GI sx--> si of heart failure (CP, fatigue, SOB) |
|
|
Term
Myocarditis
(PE, two variants) |
|
Definition
PE: may be absent, or include tachycardia, S3, b/l rales, JVD, may include fulminant HF and sudden cardiac death
Fulminant: severe hemodynamic instability, distinct onset of HF sx, fever, viral illness w/in 2wks
Acute(non-fulminant): Hemodynamically stable, no clear onset of HF sx, no fever-->DCM, endstage HF later in life |
|
|
Term
|
Definition
ECG: non-specific (t wave flat/inv, slight st elevation or dep)-not very dx
labs not overly helpful-cbc, esr, trops
+echo abnormalities-impaired systolic fx of LV, w/ absent dilation
Cardiac MRI study
Gold-standard is biopsy-restricted to fulminant, giant-cell, others |
|
|
Term
|
Definition
Supportive mostly!
HF tx-ace, bb, diuretic
mechanical LVAD, transplantation
Steroids may help for Giant cell only or if sarcoidosis? |
|
|
Term
Mitral Stenosis
(Definition, Etiology, Presentation) |
|
Definition
Mital valve thickening, calcification, fusion of leaflets, papillary muscle thickening/calcification
Etiology: Rheumatic fever/HD considered main cause
Presentation: Insidious onset, 20-40yo. Exertional dyspnea, orthopnea, PND. Rarely, hemoptysis 2/2 P-HTN, or hoarse voice 2/2 Ortner's syndrome (impingement of recurrent Laryngeal n).
|
|
|
Term
Mitral Stenosis
(PE, DX, TX) |
|
Definition
PE: opening snap, diastolic murmur best @apex, afib might be first presentation.
Dx: BNP (HF), r/o MI, echo-->leaflet thickening, motility, orifice size, etc. ECG-->LAE (p mitrale in II, biphasic P in V1)
Tx: CHF, Afib, primary prophylaxis (tx GAS w/in 7-9days), *Surgical repair/replace of valve |
|
|
Term
Mitral Valve Prolapse
(Basics) |
|
Definition
Systolic billowing of 1 or both leaflets, +/-MR, etiology mostly unknown (genetic?), usually young, otherwise healthy females
s/s: asx, maybe cp, palps, sob, PE: mid-systolic click, followed by murmur if MR
dx w/ echo, tx usually unecessary, unless major sx->repair/replace |
|
|
Term
Mitral Regurgitation
(Acute vs Chronic) |
|
Definition
acute: rapid back-up-->LAE-->flash p edema. Etiologies-MI (pap m d/f), endocarditis->leaflet perf, MVP->ruptured chordae tendinae
Chronic: asx,->HF (dyspnea, fatigue,etc)->p congestion,edema. Etiologies-MVP, annular calcifications, cardiomyopathy, rheumatic HD, MI/Endocarditis |
|
|
Term
Mitral Regurgitation
(PE, Dx, tx) |
|
Definition
Pan-systolic murmur, blowing quality, @apex->axil->scap. S3, laterally displaced apical impulse 2/2 dilation
dx: Echo(GS)->gradation mild,mod,sev
CXR->LAE,LV dilation, Pcongestion
Tx: acute->stat surgical repair/replace. Chronic->scheduled repair/replace(severe sx, EF<60%, HF) |
|
|
Term
Aortic Stenosis
(Etiology, Presentation,PE) |
|
Definition
Congenital (bicusp/unicusp valve), genetics, degenerative or calcific AS (25% of >65yo, 35% of >70yo)
S/S: stable angina, exercise assoc. syncope, CHF
PE: Harsh Sys murmur t/o precordium, best @RSB->neck |
|
|
Term
|
Definition
Dx: Echo (GS)->severity-critical=(>50mmHg, area<.08cm^2), Normal=0 mmHG, 3-4cm), *cardiac cath for assessment of CAD if surg is planned
Tx: symptomatic pt, asx pt w/ gradient >64mmHg-->bioprosthetic (elderly,10-15 year lifespan), mechanical (requires anticoagulation INR 2.0-2.5)
*Caution*-nitro,bb,diuretics. *Avoid alpha blockers* |
|
|
Term
Aortic Regurgitation
(definition, etiology, Presentation, PE) |
|
Definition
Blood flowing back into LV during diastole, -->HTN, cong bicuspid v, endocarditis
S/S: Asx until LV dysfunction-->HF signs (dyspnea, fatigue, orthopnea, angina)
PE: Diastolic murmur @Erbs, LSB, austin flint->extra blood vibrating against mitral?, water-hammer (corrigan) pulse-rapid rise/fall, widened pulse, low diastolic pressure |
|
|
Term
Aortic Regurgitation
(Dx, TX) |
|
Definition
Dx: ECG-LVH, Echo (perform annually to monitor)->amount of regurg, LV d/f
Tx: Afterload reduction-nifedipine, hydralazine, ACE inh
Surgery indicated-severe LV d/f (EF<55%, others)-bioprosthetic vs mechanical |
|
|
Term
Tricuspid Stenosis & Regurg
(Basics)
|
|
Definition
TS-rheumatic or 2/2 carcinoid syndrome->RAE, R HF, initial tx w/ diuretics, definitive tx w/ replacement
TR-Caused by RV dilation, R HF, tx underlying cause of RV dilation |
|
|
Term
Pulmonary Regurgitation
(basics) |
|
Definition
caused by p-htn, endocarditis, or carcinoid syndrome-->R HF, tx underlying cause, surgery (bioprost) |
|
|
Term
|
Definition
Left main coronary artery
left anterior descending
left circumflex
Right coronary artery |
|
|
Term
|
Definition
advanced age, family hx, male gender, htn, lipid abn, diabetes, cigs, alcohol, inactivity, abd obesity, emotional stress, low fruits/vegs |
|
|
Term
Chronic stable Angina
(Definition) |
|
Definition
Ischemia resulting from imbalance between O2 supply and demand.
Exertional sx, relieved by rest or nitro
Reproducible by similar level of exertion
Unchanged pattern x6mo |
|
|
Term
Chronic Stable Angina
(Sx-oldcart) |
|
Definition
Onset-w/ exertion, emotional stress, Location-substernal, L chest, radiation to L extremety; Duration-1-5min, no more than 15min tops; characteristics- pressure, squeezing, tightness, burning, rarely described as painful; Aggravating factors-activity, emotional stress, heavy meals; Relief-rest, nitro |
|
|
Term
Chronic Stable Angina
(PE, Dx, tx) |
|
Definition
PE; usually normal, maybe apical sys murmur, HTN->HoTN, levine si,
Dx: Labs: cbc-anemia, thyroid function-hyperthyroid can cause CP/palps, hsCRP?
ECG: +/-ST changes?/depressions, Exercise ECG, exercise tolerance test
Tx: Nitroglycerin (0.3, 0.4, 0.6 mg SL/ 0.4 buccal spray) rpt q3-5min prn
|
|
|
Term
Chronic Stable Angina
(Prevention/prophylaxis) |
|
Definition
Risk modification-quit smoking, lose weight, healthy diet/statins (cholesterol), tx HTN, exercise
Long acting nitrates-isosorbide dinitrate/mononitrate, Nitropaste, nitro patch, BB, CCB, ranolzane, aspirin/clop-last resort=PCI/CABG |
|
|
Term
Canadian Cardiovascular Society (CCS) angina Classification |
|
Definition
Class 1-angina w/ strenuous activity; Class 2-angina w/ moderate activity; Class 3-angina w/ mild exertion (climb 1flight stairs); Class 4-angina at any level of activity |
|
|
Term
Unstable Angina & NSTEMI
(Definiton-basics) |
|
Definition
-Detachment of stable clot/plaque; -partial obstruction by emboli, clot, or spasm; -obstruction leads to ischemia
|
|
|
Term
Unstable angina/NSTEMI
(si/sx, PE) |
|
Definition
Similar to stable angina, but sx of ischemia at rest or w/ minimal exertion; -if h/o stable angina, sx will be similar; - +/-dyspnea, nausea, diaphoresis, syncope
PE: usually normal, maybe-3/4th heart sound, transient MR, evidence of LV dysfunction (pulmonary congestion, edema, diaphoresis, HoTN), arrhythmias |
|
|
Term
ACS: Unstable/NSTEMI
(DX/LABS) |
|
Definition
ECG-50% normal, might show transient ST depressions or elevations; T wave inversions, flattening, peaking
LABS: Cardiac enzymes- normal in UA; Elevated in NSTEMI |
|
|
Term
|
Definition
|
|
Term
Unstable/NSTEMI: AHA diagnosis of MI |
|
Definition
-Rise/fall of cardiac biomarkers w/ at least one value above the 99th percentile of URL and evidence of ischemia; sx of cp, ischemic ecg changes, new pathologic Qwave, evidence of new loss of viable myocardium, new regional wall motion abnormality |
|
|
Term
Unstable/NSTEMI Risk assessment
(Low Risk) |
|
Definition
-new onst CCS class III or IV angina in the last 2wks w/o prolonged rest angina (>20min); Normal/unchanged ECG; Normal cardiac enzymes |
|
|
Term
Unstable/NSTEMI Risk assessment
(Intermediate Risk) |
|
Definition
Prior MI/PVD/CABG/CVA/ASA use; Resolved prolonged rest angina (>20min); Rest angina (<20min) relieved w/ rest or NTG; age>70yo; T wave inversions; Presence of pathologic Q wave; Slightly elevated cardiac enzymes |
|
|
Term
Unstable/NSTEMI risk assessment
(High Risk) |
|
Definition
Accelerating ischemic sx in last 48hrs; rest pain>20 min; presence of CHF; age>75; new BBB; Rest angina+transient ST elevations>0.5mm; sustained V-tach; Marked elevation of cardiac enzyme |
|
|
Term
|
Definition
Initial tx=MONA-morphine (or fentanyl), O2, sublingual and/or IV nitro, aspirin 162-325mg, clopidogrel 300-600 loading dose
High risk NSTEMI=aggressive care-aspirin, clopidogrel, unfx heparin or LMWH, platelet glycoprotein IIb/IIIa (tirofiban, eptifibatide), BB
All categories may ultimately recieve angiography followed by PCI/CABG, whether it is emergent or not depends on work-up/presentation |
|
|